SCHEMBL1674348

SCHEMBL1674348

CCC(=O)c1cc(Br)ccc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
GLA P06280 1/20 0.52
POLB P06746 1/20 0.48
MYC P01106 1/20 0.47
NR4A1 P22736 1/20 0.47
HSP90AB1 P08238 1/20 0.46
APEX1 P27695 1/20 0.45
SORT1 Q99523 9/20 0.44
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GPR35 Q9HC97 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16168318 0.93 KDM4E (0.52) KDM4EGLAPOLBMYCNR4A1
SCHEMBL618056 0.82 KDM4E (0.65) KDM4EGLAMYCNR4A1APEX1
SCHEMBL6174178 0.81 HSP90AB1 (0.48) POLBHSP90AB1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL4441828 0.80 KDM4E (0.63) KDM4EGLAMYCNR4A1APEX1
SCHEMBL22552343 0.80 TSHR (0.53) MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL15884062 0.79 MEN1 (0.43) KDM4EGLAPOLBMYCNR4A1
SCHEMBL1922044 0.79 HSP90AB1 (0.47) POLBHSP90AB1MEN1KMT2ASMN1; SMN2
SCHEMBL7534898 0.79 HSP90AB1 (0.67) KDM4EPOLBHSP90AB1TDP1MEN1
SCHEMBL22305152 0.79 MAPT (0.43) KDM4EGLAPOLBMYCNR4A1
SCHEMBL30863507 0.79 HSP90AB1 (0.67) KDM4EPOLBHSP90AB1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114174278-B Dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2024-08-23 CN disclosed
EP-3956320-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2023-11-29 EP disclosed
US-11753393-B2 Dihydroorotate dehydrogenase inhibitors JANSSEN BIOTECH, INC. 2023-09-12 US disclosed
US-11505536-B2 Dihydroorotate dehydrogenase inhibitors JANSSEN BIOTECH, INC. 2022-11-22 US disclosed
US-20220298137-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2022-09-22 US disclosed
CN-114174278-A Dihydroorotate dehydrogenase inhibitors 詹森生物科技公司 2022-03-11 CN disclosed
EP-3956320-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Janssen Biotech, Inc. (US) 2022-02-23 EP disclosed
US-20200331881-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2020-10-22 US disclosed
WO-2020212897-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2020-10-22 WO disclosed
US-20110097766-A1 1,2 - ADDITION OF CARBONYL COMPOUNDS USING THE ENZYME YERE ALBERT-LUDGWIGS-UNIVERSITÄT FREIBURG (DE) 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753393-B2 Dihydroorotate dehydrogenase inhibitors DHODH, DLD, DPYD KDM4E 1797/4885GLA 1239/4885POLB 621/4885
US-11505536-B2 Dihydroorotate dehydrogenase inhibitors DHODH, DLD, DPYD KDM4E 1797/4885GLA 1239/4885POLB 621/4885
US-20220298137-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD KDM4E 1797/4885GLA 1239/4885POLB 621/4885
US-20200331881-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD KDM4E 1797/4885GLA 1239/4885POLB 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.